When the Reserve Bank of Australia wanted to develop new security technologies for bank notes, Prof Jim Piper’s Advanced Imaging research group in the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) at Macquarie University had an answer: timecoded nanoparticles. Continue reading
CNBP has officially welcomed UNSW, one of the world’s leaders at translational engineering research, as its newest node.
In addition to the official open by UNSW Engineering Dean Professor Mark Hoffman, CNPB Director Professor Mark Hutchinson took the opportunity to lay out the CNBP mission and its accomplishments at an industry showcase. Continue reading
A new collaboration agreement has been announced today by Macquarie University and clinical-stage regenerative medicine company Regeneus Ltd, to commercialise a breakthrough cell selection technology that for the first time allows high potency secreting stem cells to be identified and selected for the manufacture of next generation cell therapies.
The technology was developed in a research group led by Professor Ewa Goldys and Dr Guozhen Liu at the Australian Research Council’s Centre of Excellence for Nanoscale BioPhotonics (CNBP) at Macquarie, and uses innovative cell labelling technologies to identify and select cells based on the molecules that they are secreting rather than their surface characteristics used currently.
Read more here:
CNBP’s latest partner launch successfully took place 3 July 2015, with industry partner Olympus, at Olympus Headquarters, Tokyo, Japan.
The launch and associated visit over two days, saw members of the CNBP leadership team (Mark Hutchinson, Jim Piper, Brant Gibson, and Mel Trebilcock) meet with key Olympus Executives to actively reinforce and advance collaboration between both organisations, with a view to facilitating Industry-Research benefits for both parties.
With presentations from both CNBP and Olympus Executives, a symbolic CNBP offering of plaque and handmade scientific symbols, as well as a number of associated meetings, the launch was seen as highly successful by the Centre, with a number of positive outcomes. This included the broadening of the CNBP and Olympus personal relationships, the development of clearly defined expectations and involvement of both partners, as well as the clear communication of CNBP’s commitment to commercial outcomes with long term societal impact, in alignment with Olympus corporate vision.
Wide-ranging dialogue on future partnership opportunities were also undertaken by participants, with CNBP Director Mark Hutchinson noting that he saw value in “growing CNBP collaboration with Olympus in all three of its corporate domains – medical, science and imaging.” And that talks with Olympus in this regard had proved encouraging.
Discussions on the future directions of the partnership with Olympus and CNBP, both within Australia and internationally had also been promising said Hutchinson. Olympus currently funds two researchers, located at CNBP’s Macquarie University node in Sydney, Australia. Agreement by both partners to explore opportunities provided by the Australian Government Beacon fellowship scheme for short term international research collaborations was also a positive.
Feedback from Olympus Australia, who were in attendance at the launch, advised that Olympus HQ had a very good understanding of both the relationship and expectations of the partnership. Also, that the strategies of both organisations were well aligned in aiming to discover, develop and produce products, which will have a long term contribution and beneficial impact to society.
The CNBP visit included a tour of the head office of the Olympus Tokyo corporate area, as well as the training facility – the Olympus Techno Lab – and concluded on the second day with a tour and additional related meetings and presentations at the Olympus R&D facility.
Hutchinson, in summing up the launch, expressed pleasure in the “open interaction and around-the-table discussions with Mr Okubo, Mr Inoue and Mr Arinobe from Olympus Tokyo”, noting that the Olympus Executives had “seemed impressed by CNBP’s approach and model to translational research.” He concluded, “Olympus is a valued member of our partner global partnership network, which is continuing to grow within industry, university and government environments.”
Key personnel in attendance from Olympus Tokyo Headquarters for the launch were:
• Mr Toshihiko Okubo, Executive Officer Division Manager, Scientific Solutions Business Strategy Division and Scientific Solutions Business Global Marketing Division
• Mr Motoki Inoue, Manager Sales Marketing 1-Group, Scientific Solutions Sales and Marketing Department and Scientific Solutions Business Strategy Division
• Mr Eisuke Arinobe, Manager Academy Planning Group, Scientific Solutions Sales and Marketing Department and Scientific Solutions Business Strategy Division
Key personnel in attendance from Olympus Australia for the launch were:
• Mr JianShen, Sales Manager, MIS – Olympus Australia
• Dr. Kim Everuss, Sales Manager, MIS – Olympus Australia
Key personnel in attendance from the Centre for Nanoscale BioPhotonics for the launch were:
• Prof Mark Hutchinson, CNBP Director
• Prof Jim Piper, CNBP Node Leader, Macquarie University
• A/Prof Brant Gibson, CNBP Node Leader, RMIT University
• Ms Melodee Trebilcock, CNBP Business Development and Events Officer
CNBP celebrated a successful launch with industry partner Heraeus, in Hanau, Germany on the 30th March 2015.
Taking place at the Heraeus Quarzglas division, the launch was attended by CNBP Investigator A/Prof Heike Ebendorff-Heidepriem and hosted by Dr Gerhard Schoetz, General Manager of Heraeus Specialty Fiber Optics.
As part of the launch, Ebendorff-Heidepriem met with a number of senior Heraeus executives, provided a presentation about the optical fiber sensor research taking place at CNBP, provided an overview of the CNBP (the scope of the research themes and the biological challenges that the CNBP aims to solve), and talked through related photonics research taking place across Australia.
Ebendorff-Heidepriem and Heraeus executives also discussed a wide range of topics during the launch, including the properties of different silica types and behaviors, particularly relating to extrusion and fiber drawing processes. Information on silica items in stock and silica items that could be made on demand was also provided and agreement on the supply of F110 silica rods to fabricate UV transmitting silica fiber was also made.
Heraeus, the world’s largest manufacturer of synthetic fused silica brings to the CNBP longstanding and extensive knowledge in silica glass types and properties. The corporation’s expertise will be critical for the fabrication of specialty silica fibers and for the selection and development of suitable silica types for specific fiber sensor application, for use within the CNBP.
The launch was highly successful, strengthening industry and research links across the CNBP, with the possibility of Heraeus attendance at related Australasian conferences and at the annual CNBP retreat also discussed.